---
title: "Sanara MedTech (SMTI) stock: news and investor profile"
url: "https://aibio.space/companies/sanara-medtech/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "Sanara MedTech Inc. (NASDAQ: SMTI), United States. Listing facts, related biotech companies and news on aibio.space."
---

SMTI Sanara MedTech Inc. NASDAQ · United States

# Sanara MedTech (SMTI) news

Sanara MedTech Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker SMTI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest Sanara MedTech news

We have not published a story on Sanara MedTech yet. When there is news, it will appear here.

## Sanara MedTech at a glance

- **Ticker**: SMTI

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Jun 30, 2026**: $15.4 million

### Related companies

- [RAPID MICRO BIOSYSTEMS, INC.](https://aibio.space/companies/rapid-micro-biosystems/) NASDAQ: RPID
- [RETRACTABLE TECHNOLOGIES INC](https://aibio.space/companies/retractable-technologies/) NYSE: RVP
- [NeuroPace](https://aibio.space/companies/neuropace/) NASDAQ: NPCE
- [LogicMark](https://aibio.space/companies/logicmark/) OTC: LGMK
- [Stimcell Energetics](https://aibio.space/companies/stimcell-energetics/) OTC: STME
- [IDEXX LABORATORIES INC /DE](https://aibio.space/companies/idexx-laboratories-de/) NASDAQ: IDXX
- [VASO](https://aibio.space/companies/vaso/) OTC: VASO
- [Glass House Brands](https://aibio.space/companies/glass-house-brands/) NYSE: GLAS

### Also on NASDAQ

- [Burning Rock Biotech](https://aibio.space/companies/burning-rock-biotech/) BNR
- [Neurogene](https://aibio.space/companies/neurogene/) NGNE
- [Passage Bio](https://aibio.space/companies/passage-bio/) PASG
- [Rapport Therapeutics](https://aibio.space/companies/rapport-therapeutics/) RAPP
- [Mangoceuticals](https://aibio.space/companies/mangoceuticals/) MGRX
- [Vir Biotechnology](https://aibio.space/companies/vir-biotechnology/) VIR

## Sanara MedTech annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Research and development | [$5.1 million](https://www.sec.gov/Archives/edgar/data/714256/000149315226012352/) | [$2.8 million](https://www.sec.gov/Archives/edgar/data/714256/000149315226012352/) |
| Net income (loss) | [-$37.6 million](https://www.sec.gov/Archives/edgar/data/714256/000149315226012352/) | [-$9.7 million](https://www.sec.gov/Archives/edgar/data/714256/000149315226012352/) |
| Cash from operations | [$6.8 million](https://www.sec.gov/Archives/edgar/data/714256/000149315226012352/) | [-$23,784](https://www.sec.gov/Archives/edgar/data/714256/000149315226012352/) |
| Cash and equivalents | [$16.6 million](https://www.sec.gov/Archives/edgar/data/714256/000149315226037176/) | [$15.9 million](https://www.sec.gov/Archives/edgar/data/714256/000149315226012352/) |

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $15.4 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about Sanara MedTech

What is the ticker symbol of Sanara MedTech?

Sanara MedTech Inc. trades under the ticker SMTI on NASDAQ.

Where is Sanara MedTech listed?

Sanara MedTech Inc. is listed on NASDAQ.

Which country or territory is Sanara MedTech listed under?

Our directory records Sanara MedTech Inc. under United States.

Does aibio.space cover Sanara MedTech?

aibio.space lists Sanara MedTech Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Is Sanara MedTech profitable?

Sanara MedTech Inc. reported a net loss of $37.6 million for the fiscal year ended Dec 31, 2025, and generated $6.8 million of cash from operations, per its annual report to the SEC.

How much does Sanara MedTech spend on research and development?

$5.1 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Sanara MedTech have?

$15.4 million in cash at Jun 30, 2026, per its 10-Q.

## Investor discussion: Sanara MedTech

Members talk about Sanara MedTech (SMTI). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at Sanara MedTech, newest first. Each line links the filing it comes from.

1. 2026-07-29 Mergers Reported a merger or acquisition agreement. SEC Form 8-K (Items 1.01,7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/714256/000149315226035196/ex99-1.htm)
2. 2026-06-04 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02). [Source](https://www.sec.gov/Archives/edgar/data/714256/000149315226027274/form8-k.htm)

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:SMTI on TradingView](https://www.tradingview.com/symbols/NASDAQ-SMTI/).

## Listing details

Sanara MedTech Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker SMTI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: Sanara MedTech Inc.

- **Ticker**: SMTI

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/sanara-medtech/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Sanara MedTech (SMTI) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/sanara-medtech/
